SCHEMBL9748117

SCHEMBL9748117

COCOc1c(C=O)ccc2ccccc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 2/20 0.47
GAA P10253 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
TDP1 Q9NUW8 1/20 0.41
ADRB2 P07550 1/20 0.40
ADRB1 P08588 1/20 0.40
MAPT P10636 2/20 0.39
ALDH1A1 P00352 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
MCL1 Q07820 1/20 0.39
CYP1A2 P05177 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
POLB P06746 2/20 0.37
PTPN1 P18031 2/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
CYP1A1 P04798 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3563735 0.82 ERN1 (0.61) ERN1GAAL3MBTL1TDP1MAPT
SCHEMBL11926109 0.80 CA1 (0.36) ERN1GAAL3MBTL1ALDH1A1SMN1; SMN2
SCHEMBL31674421 0.80 MAPT (0.49) ERN1GAAL3MBTL1TDP1ADRB2
SCHEMBL30071915 0.79 ERN1 (0.51) ERN1GAAL3MBTL1TDP1ADRB2
SCHEMBL5138904 0.78 RAB9A (0.60) ERN1L3MBTL1MAPTSMN1; SMN2NPC1
SCHEMBL29052130 0.78 ERN1 (0.47) ERN1GAAL3MBTL1TDP1MAPT
SCHEMBL20563726 0.78 ERN1 (0.50) ERN1GAAL3MBTL1TDP1ADRB2
SCHEMBL8749413 0.78 GAA (0.55) ERN1GAAL3MBTL1TDP1ADRB2
SCHEMBL9484213 0.78 GAA (0.55) ERN1GAAL3MBTL1TDP1ADRB2
SCHEMBL29618406 0.77 ERN1 (0.44) ERN1GAAL3MBTL1TDP1ADRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014141110-A2 AMINONITRILES AS KYNURENINE PATHWAY INHIBITORS CURADEV PHARMA PVT. LTD. (IN) 2014-09-18 WO disclosed
WO-2014141110-A2 AMINONITRILES AS KYNURENINE PATHWAY INHIBITORS CURADEV PHARMA PVT. LTD. (IN) 2014-09-18 WO disclosed
EP-0201071-B1 2-SUBSTITUTED-1-NAPHTHOLS AS 5-LIPOXYGENASE INHIBITORS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1992-03-04 EP disclosed
US-5026759-A Antiinflammatory agents respiratory system disorders DU PONT MERCK PHARMACEUTICAL (US) 1991-06-25 US disclosed
US-4985442-A ANTIINFLAMMATORY, LUNG DISEASES, PSORIASIS E. I. DU PONT DE NEMOURS AND COMPANY (US) 1991-01-15 US disclosed
US-4985435-A TREATMENT OF INFLAMMATION, OBSTRUCTIVE LUNG DISEASES AND PSORIASIS E. I. DU PONT DE NEMOURS AND COMPANY (US) 1991-01-15 US disclosed
US-4906636-A 2-Substituted-1-naphthols as 5-lipoxygenase inhibitors E. I. DU PONT DE NEMOURS AND COMPANY (US) 1990-03-06 US disclosed
US-4833164-A ANTIINFLAMMATORY AGENTS E. I. DU PONT DE NEMOURS AND COMPANY (US) 1989-05-23 US disclosed
EP-0201071-A2 2-Substituted-1-naphthols as 5-lipoxygenase inhibitors THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1986-11-12 EP disclosed